ZTS
40
2
TSCO
48
5
PEP
36
3
AON
30
2
DAL
64
3
PX
58
5
AIZ
66
3
MCO
73
5
BK
61
3
NRG
39
4
RCL
76
3
PNR
60
3
AMZN
63
5
UNP
40
2
FRT
39
3
PEG
57
2
ACN
54
4
IFF
47
3
ZION
52
3
ROST
62
2
ZTS
40
2
TSCO
48
5
PEP
36
3
AON
30
2
DAL
64
3
PX
58
5
AIZ
66
3
MCO
73
5
BK
61
3
NRG
39
4
RCL
76
3
PNR
60
3
AMZN
63
5
UNP
40
2
FRT
39
3
PEG
57
2
ACN
54
4
IFF
47
3
ZION
52
3
ROST
62
2
Financhill
Back

PTC Therapeutics Stock Predictions

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
31

PTCT
PTC Therapeutics

Last Price:
$45.41
Seasonality Move:
7.01%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

PTC Therapeutics Stock Forecast

  • Over the next 52 weeks, PTC Therapeutics has on average historically risen by 26% based on the past 11 years of stock performance.
  • PTC Therapeutics has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
  • Is PTC Therapeutics Stock Undervalued?
    The current PTC Therapeutics [PTCT] share price is $45.35. The Score for PTCT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will PTC Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, PTC Therapeutics has on average historically risen by 26% based on the past 11 years of stock performance.

PTC Therapeutics Stock Rating

Sell
31
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics overpriced?

  • PTC Therapeutics has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%

PTC Therapeutics Stock Price History

Is PTCT stock going to rise?

  • The current trend is moderately bearish and PTCT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ptcbio.com

52-Week Data

52-Week High:
54.16
52-Week Low:
23.58

Prediction Charts

Market Cap:
3.5B
Price in USD:
45.35
Volume:
185.8K
Beta:
0.85

Technical Analysis

SMA50:
43.68
SMA100:
39.10
SMA200:
35.59
52-Wk Change:
64.25%

Stock Predictions

  • Is PTC Therapeutics stock public?
    Yes, PTC Therapeutics is a publicly traded company.
  • What is the PTC Therapeutics stock quote today?
    The PTC Therapeutics stock price is 45.35 USD today.
  • How to buy PTC Therapeutics stock online?
    You can buy PTC Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 48.53 48.40 49.50 47.75
Dec-6 48.00 48.04 49.44 47.88
Dec-9 47.54 48.06 48.55 46.66
Dec-10 50.00 49.99 51.74 49.44
Dec-11 50.00 49.67 50.20 49.06
Dec-12 49.52 47.36 49.89 47.03
Dec-13 49.34 46.37 49.35 46.33
Dec-16 46.30 48.61 48.77 46.00
Dec-17 47.77 47.02 48.61 46.66
Dec-18 47.51 45.52 48.04 44.30
Dec-19 45.66 45.25 46.56 44.97
Dec-20 44.77 46.24 47.42 44.74
Dec-23 46.09 45.56 46.23 44.52
Dec-24 45.56 45.35 46.15 44.95

PTC Therapeutics Earnings

PTC Therapeutics Earnings Report: Per Share PTC Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

PTC Therapeutics Forecast Revenue Growth

PTC Therapeutics Stock Analysis: Historical quarterly revenues per share for PTC Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.07 per share, and an increase next year of $0.14 per share.

* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.